MMJ Group Holdings Ltd (MMJJF) MediPharm Labs Signs $35 Million Private Label Cannabis Oil

About this update from Medipharm Labs Corp.

[{"type":"text","content":"MMJ Group Holdings Ltd (MMJJF) MediPharm Labs Signs $35 Million Private Label Cannabis Oil\nPerth, Australia (ABN Newswire) - MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) attaches a copy of a recent news release by MediPharm Labs Inc (\"MediPharm Labs\") (CVE:LABS) (OTCMKTS:MLCPF) announcing that MediPharm Labs signed a CAD35m private label cannabis oil sale agreement with an option for additional CAD13.5m. MMJ owns approximately 3.9m shares (at a cost of CAD$0.85 per share) and 2.9m warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs. The book value of MMJ's investment in Medipharm Labs is AUD15m. MMJ's post-tax net tangible asset backing per share was approximately 31 cents per share as at 13 February 2019 (AEDT). To view the MediPharm release, please visit:http://abnnewswire.net/lnk/C0OHBA15 \nAbout MMJ Group Holdings Ltd:MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/ \nSource:MMJ Group Holdings Ltd\nContact:Investor and Media Enquiries:\nJason Conroy\nChief Executive Officer\nT: +61-2-8098-0819\nE: [email protected]\n \n ","length":1703,"tagName":"div"}]

More updates from Medipharm Labs Corp.